'Rocketing' Stock Price for Rare Disease Firm; Good News for California Stem Cell Agency
UCLA scientist involved in funding for two clinical trials
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.